Get the Stockscreener App
129.07
1.58%
-2.07
Pre-market:
132.95
3.88
+3.01%
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $129.07, with a volume of 2.14M.
It is down -1.58% in the last 24 hours and down -2.73% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$131.14
Open:
$129.09
24h Volume:
2.14M
Relative Volume:
0.95
Market Cap:
$36.45B
Revenue:
$7.23B
Net Income/Loss:
$1.41B
P/E Ratio:
25.92
EPS:
4.979
Net Cash Flow:
$1.09B
1W Performance:
-3.24%
1M Performance:
-2.73%
6M Performance:
-11.45%
1Y Performance:
+6.66%
1-Day Range:
$127.46
$129.59
1-Week Range:
$127.46
$134.48
52-Week Range:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
129.07 | 36.45B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
510.13 | 189.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
190.77 | 135.02B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
555.67 | 43.83B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
274.39 | 39.30B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis - Business Wire
Jefferies resumes Agilent stock coverage with Hold rating - Investing.com
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies earnings and business outlook. Investors focus on diagnostics and life sciences - Ad-hoc-news.de
Agilent Expands HPLC Column Portfolio to Enhance Biotherapeutic Analysis - Contract Pharma
Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis - marketscreener.com
Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize? - Yahoo Finance
Agilent Slumps on Expansion Plans - TradingView
Agilent expands Altura HPLC column portfolio for biopharma - Investing.com
Agilent adds inert columns for tougher biopharma tests - Stock Titan
Agilent adds SEC and PLRP-S columns to Altura portfolio - StreetInsider
Agilent Technologies focuses on analytical solutions as investors watch long-term growth - Ad-hoc-news.de
Agilent 1260 Infinity II LC from Agilent Technologiesworkhorse HPLC for busy US labs - AD HOC NEWS
Agilent 6560 Ion Mobility LC/Q-TOF from Agilentniche lab workhorse gains quiet momentum - AD HOC NEWS
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis - AOL.com
Agilent (A) Stock Looks Below Fair Value On Cash Flow - Yahoo Finance
Agilent Announces Cash Dividend of 25.5 Cents per Share - AOL.com
Agilent Technologies focuses on lab instrumentation and diagnostics - AD HOC NEWS
Evercore Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $148 - Moomoo
Agilent rises on Q2 beats; adjusts fiscal 2026 guidance - MSN
Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 - marketscreener.com
Agilent Technologies focuses on analytical tools for growth - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Strong Buy Ratings Signal a Potential 22.68% Upside - DirectorsTalk Interviews
Agilent Technologies stock follows a data-light setup. Investors watch the next filing cycle. - AD HOC NEWS
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Agilent Technologies focuses on lab instrumentation and diagnostics as investors weigh the long-term - AD HOC NEWS
Agilent (A) Launches AI Cell Imaging Software For Biopharma Research - Sahm
Agilent Technologies steadies on business focus. - AD HOC NEWS
AAgilent Technologies Inc Latest SEC Filings - Finviz
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Agilent (A) Unveils AI-Enhanced Software for Improved Cell Imagi - GuruFocus
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight - 巴士的報
Agilent 1260 Infinity II LC System from Agilent Technologies Inc.midrange workhorse for US analyt - AD HOC NEWS
Agilent TechnologiesIgnite raises the full-year outlook - AD HOC NEWS
Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc.Automating genomic workflows for - AD HOC NEWS
Jefferies Initiates Agilent Technologies(A.US) With Buy Rating, Announces Target Price $550 - Moomoo
Agilent Technologies consensus picture, shares trade steadily on the NYSE - AD HOC NEWS
Form 4 Agilent Technologies For: 29 June By Investing.com - Investing.com South Africa
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent (NYSE: A) SVP surrenders 30 shares to cover RSU tax liability - Stock Titan
InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.flexible mid-range workhorse - AD HOC NEWS
Accurate mAb Sizing Using The NIST mAb As A Ladder For The Agilent ProteoAnalyzer System - Bioprocess Online
Agilent Technologies sets $600 million note deal, shares supported by debt market access - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors - DirectorsTalk Interviews
Agilent Inlet Liners from Agilent Technologies Inc.small glass parts, big impact on GC precision - AD HOC NEWS
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
The 8890 GC System from Agilent Technologies Inc.a classic gas chromatograph for modern labs - AD HOC NEWS
InfinityLab LC Series from Agilent Technologies Inc.modular HPLC workhorse for busy labs - Ad-hoc-news.de
Agilent Completes Acquisition Of Biocare Medical - Pulse 2.0
Agilent lifts outlook after Q2, shares hold above consensus - Ad-hoc-news.de
Enterprise value to EBIT forward of Agilent Technologies, Inc. – BOATS:A - TradingView
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):